Stay up to date on research and information
Sign Up for FORCE NewslettersHereditary Prostate Cancer Treatment
Heather Cheng, MD, PhD
November 20, 2020
This expert-led webinar presented by Heather Cheng, MD, PhD, discusses the importance of identifying hereditary cancer risk mutations for prostate cancer. Dr. Cheng discusses prostate cancer treatment and trials, as well as, screening trials for men with hereditary prostate cancer.
About Our Speaker
Dr. Heather Cheng, MD, PhD, is an Associate Professor in Medicine (Oncology Division) at the University of Washington, an Associate Member of the Division of Clinical Research at the Fred Hutch Cancer Research Center and is Director of the Prostate Cancer Genetics Clinic at the Seattle Cancer Care Alliance. As a medical oncologist she designs and conducts therapeutic clinical trials, particularly for men whose cancers have mutations in genes related to DNA repair, such as BRCA2, BRCA1.
People concerned about hereditary prostate cancer, cancer survivors and health care providers.